Antiphospholipid antibodies: Paradigm in transition
暂无分享,去创建一个
Amir | A. Minagar | R. Zivadinov | L. Horstman | W. Jy | C. Bidot | Y. Ahn | M. Etemadifar | A. Maghzi | R. Kelley | Wenche | Robert | A. Mousavi | Roger | H. Maghzi | Robert Zivadinov | Carlos J. Bidot | Roger E Kelley | Wenche | Masoud Etemadifar | Seyed Ali Mousavi | Alireza Minagar | Masoud Etemadifar | Seyed Ali Mousavi
[1] K. Ghosh,et al. Thrombophilic dimension of recurrent fetal loss in Indian patients , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[2] Monica Galli1. Clinical Utility of Laboratory Tests Used to Identify Antiphospholipid Antibodies and to Diagnose the Antiphospholipid Syndrome , 2008 .
[3] Sergio E. Baranzini,et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets , 2008, Nature.
[4] G. Atsumi,et al. Sole existence of antithrombin antibody in patients with systemic lupus erythematosus showing tendency of its antigenic determinants directing against exosite II (antithrombin/heparin binding site) of thrombin , 2008, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[5] M. Oppermann,et al. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. , 2007, Blood.
[6] P. D. de Groot,et al. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. , 2007, Blood.
[7] T. Barbui,et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. , 2007, Blood.
[8] F. Rosendaal,et al. Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis , 2007, Journal of thrombosis and haemostasis : JTH.
[9] S. Sánchez-Ramón,et al. Isolated type 5 antimitochondrial autoantibodies are associated with a history of thrombocytopenia and fetal loss. , 2007, Fertility and sterility.
[10] C. Bai,et al. High Titer of Anticardiolipin Antibody Is Associated with First-Ever Ischemic Stroke in Taiwan , 2006, Cerebrovascular Diseases.
[11] L. Horstman,et al. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS) , 2006, American journal of hematology.
[12] J. Lifson,et al. Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions. , 2006, Blood.
[13] T. Koike,et al. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. , 2005, Immunobiology.
[14] Bihui Huang,et al. Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. , 2005, Blood.
[15] E. Santagostino,et al. Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants. , 2005, Clinical chemistry.
[16] D. Sblattero,et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. , 2005, Blood.
[17] B. Lämmle,et al. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. , 2005, Blood.
[18] P. Lollar,et al. Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor , 2005, Journal of thrombosis and haemostasis : JTH.
[19] M. Turiel,et al. Thrombotic Risk Factors In Primary Antiphospholipid Syndrome: A 5-Year Prospective Study , 2005, Stroke.
[20] A. Kelemen,et al. Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with antithrombin antibody from a patient with antiphospholipid syndrome , 2005, Thrombosis and Haemostasis.
[21] Y. Ikeda,et al. Binding of beta 2-glycoprotein I to anionic phospholipids facilitates processing and presentation of a cryptic epitope that activates pathogenic autoreactive T cells. , 2005, Blood.
[22] L. Horstman,et al. Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission , 2005, British journal of haematology.
[23] J. Gris,et al. Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. , 2004, Blood.
[24] Takao Koike,et al. Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis. , 2004, Blood.
[25] Pojen P. Chen,et al. Identification of Anti-Plasmin Antibodies in the Antiphospholipid Syndrome That Inhibit Degradation of Fibrin1 , 2004, The Journal of Immunology.
[26] L. Horstman,et al. Endothelial microparticles as markers of endothelial dysfunction. , 2004, Frontiers in bioscience : a journal and virtual library.
[27] R. Russo,et al. Antibodies to tissue-type plasminogen activator (tPA) in patients with antiphospholipid syndrome: evidence of interaction between the antibodies and the catalytic domain of tPA in 2 patients. , 2004, Blood.
[28] S. Rezende,et al. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. , 2004, Blood.
[29] C. Haslett,et al. Eat Me or Die , 2003, Science.
[30] T. Barbui,et al. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. , 2003, Blood.
[31] B. Dahlbäck,et al. Molecular recognition in the protein C anticoagulant pathway , 2003, Journal of thrombosis and haemostasis : JTH.
[32] R. K. Miller,et al. The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture , 2003, Lupus.
[33] A. Korczyn,et al. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer , 2003, Lupus.
[34] P. D. de Groot,et al. A simple method to discriminate between β2‐glycoprotein I‐ and prothrombin‐dependent lupus anticoagulants , 2003, Journal of thrombosis and haemostasis : JTH.
[35] J. Hall,et al. E‐Selectin mediates pathogenic effects of antiphospholipid antibodies , 2003, Journal of thrombosis and haemostasis : JTH.
[36] M. Martinuzzo,et al. High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome , 2003, Journal of thrombosis and haemostasis : JTH.
[37] T. Barbui,et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. , 2003, Blood.
[38] L. Carreras,et al. Link between anti-CD36 antibodies and thrombosis in the antiphospholipid syndrome. , 2003, Clinical and experimental rheumatology.
[39] L. Horstman,et al. Factor VII/VIIa: a new antigen in the anti‐phospholipid antibody syndrome , 2003, British journal of haematology.
[40] G. Willems,et al. Kinetics of prothrombin-mediated binding of lupus anticoagulant antibodies to phosphatidylserine-containing phospholipid membranes: an ellipsometric study. , 2002, Biochemistry.
[41] L. Horstman,et al. Vascular dementia in patients with immune thrombocytopenic purpura. , 2002, Thrombosis research.
[42] K. Yeo,et al. Lot-to-lot inconsistency of anticardiolipin reagents. , 2002, Clinical chemistry.
[43] T. Kveder,et al. Inter-laboratory variability of anti-beta2-glycoprotein I measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. , 2002, Thrombosis and haemostasis.
[44] J. Vostal,et al. Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin , 2002, BMC Cell Biology.
[45] B. Villoutreix,et al. Characterization and Structural Impact of Five Novel PROS1 Mutations in Eleven Protein S-deficient Families , 2001, Thrombosis and Haemostasis.
[46] H. Homburger,et al. Persistent Problems with Standardization of Immunoassays for Anti-Cardiolipin Antibodies , 2001, Thrombosis and Haemostasis.
[47] T. Koike,et al. Anticardiolipin Antibody Assay: a Methodological Analysis for a better Consensus in Routine Determinations , 2001, Thrombosis and Haemostasis.
[48] S. Madoiwa,et al. Autoantibody against prothrombin aberrantly alters the proenzyme to facilitate formation of a complex with its physiological inhibitor antithrombin III without thrombin conversion. , 2001, Blood.
[49] T. Zima,et al. Antibodies against oxidized LDL in infants. , 2001, Clinical Chemistry.
[50] A. Minagar,et al. Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.
[51] D. Isenberg,et al. Anti‐prothrombin antibodies: assay conditions and clinical associations in the anti‐phospholipid syndrome , 2001, British journal of haematology.
[52] E. Kruithof,et al. Localization of β2-Glycoprotein 1 in Late Endosomes of Human Endothelial Cells , 2001, Thrombosis and Haemostasis.
[53] D. W. Jones,et al. Antibodies to factor XII and recurrent fetal loss in patients with the anti‐phospholipid syndrome , 2001, British journal of haematology.
[54] M. Alessi,et al. Antibodies to Phosphatidylethanolamine as the only Antiphospholipid Antibodies Found in Patients with Unexplained Thromboses , 2001, Thrombosis and Haemostasis.
[55] L. Vallar,et al. β2-glycoprotein I Binding to Platelet Microparticle Membrane Specifically Reduces Immunoreactivity of Glycoproteins IIb/IIIa , 2001, Thrombosis and Haemostasis.
[56] G. FitzGerald,et al. Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E. , 2001, Blood.
[57] K. Miyamoto,et al. Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[58] P. Hogg,et al. Dependence on Prothrombin for Inhibition of Activated Protein C Activity by Lupus Antibodies , 2000, Thrombosis and Haemostasis.
[59] G. Hughes,et al. Systemic Endothelial Cell Markers in Primary Antiphospholipid Syndrome , 2000, Thrombosis and Haemostasis.
[60] G. Willems,et al. Antibodies to β2-Glycoprotein I Associated with Antiphospholipid Syndrome Suppress the Inhibitory Activity of Tissue Factor Pathway Inhibitor , 2000, Thrombosis and Haemostasis.
[61] M. Galli. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome? , 2000, Journal of autoimmunity.
[62] A. Tsutsumi,et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. , 2000, Arthritis and rheumatism.
[63] J. Kingdom,et al. Ontogeny of Beta 2 Glycoprotein I and Annexin V in Villous Placenta of Normal and Antiphospholipid Syndrome Pregnancies , 2000, Thrombosis and Haemostasis.
[64] M. Khamashta,et al. Antiphospholipid antibodies and the endothelium , 2000, Current rheumatology reports.
[65] K. Matsuda,et al. Detection of Complement-fixing Antiphospholipid Antibodies in Association with Thrombosis , 2000, Thrombosis and Haemostasis.
[66] E. Angles-cano,et al. Antibodies to tissue‐type plasminogen activator in plasma from patients with primary antiphospholipid syndrome , 2000, British journal of haematology.
[67] G. Willems,et al. Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes. , 2000, Biochemistry.
[68] M. Lindsay,et al. Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[69] B. Boyanovsky,et al. High Levels of IgA Anticardiolipin Antibodies in Patients with Systemic Lupus erythematosus, Henoch-Schoenlein Purpura, Sneddon’s Syndrome and Recurrent Pregnancy Loss , 1999, Thrombosis and Haemostasis.
[70] M. Manco-Johnson,et al. Evidence for Antiphospholipid Antibodies in Hemophilic Children with Factor VIII Inhibitors , 1999, Thrombosis and Haemostasis.
[71] J. Rand,et al. A Possible Solution to the Paradox of the “Lupus Anticoagulant”: Antiphospholipid Antibodies Accelerate Thrombin Generation by Inhibiting Annexin-V , 1999, Thrombosis and Haemostasis.
[72] R. Schiaffini,et al. Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus , 1999, Clinical and experimental immunology.
[73] F. Bernini,et al. Natural anti-endothelial cell antibodies (AECA). , 1999, Journal of autoimmunity.
[74] C. Esmon,et al. Endothelial Protein C Receptor , 1999, Thrombosis and Haemostasis.
[75] G. Grau,et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.
[76] J. Merrill,et al. Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein. , 1999, Thrombosis and haemostasis.
[77] L. Horstman,et al. Platelet microparticles: a wide-angle perspective. , 1999, Critical reviews in oncology/hematology.
[78] D. Isenberg,et al. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. , 1999, Arthritis and rheumatism.
[79] T. Koike,et al. Platelet Activation Induced by Combined Effects of Anticardiolipin and Lupus Anticoagulant IgG Antibodies in Patients with Systemic Lupus Erythematosus , 1999, Thrombosis and Haemostasis.
[80] D. W. Jones,et al. Antibodies to Factor XII Associated with Lupus Anticoagulant , 1999, Thrombosis and Haemostasis.
[81] R W Evans,et al. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. , 1999, Clinical immunology.
[82] J. Provenzale,et al. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? , 1999, Lupus.
[83] Pojen P. Chen,et al. Possible presence of enhancing antibodies in idiopathic thrombocytopenic purpura , 1999, British journal of haematology.
[84] L. Horstman,et al. Anti‐CD36 autoantibodies in thrombotic thrombocytopenic purpura and other thrombotic disorders: identification of an 85 kD form of CD36 as a target antigen , 1998, British journal of haematology.
[85] I. Chaiken,et al. Heterogeneity of anti-phospholipid and anti-endothelial cell antibodies. , 1998, Journal of autoimmunity.
[86] G. Hughes,et al. Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. , 1998, British journal of rheumatology.
[87] Phipps,et al. Anti‐endothelial cell antibodies in primary antiphospholipid syndrome and SLE: patterns of reactivity with membrane antigens on microvascular and umbilical venous cell membranes , 1998, British journal of haematology.
[88] J. Gris,et al. Primary recurrent miscarriages: anti-beta2-glycoprotein I IgG antibodies induce an acquired activated protein C resistance that can be detected by the modified activated protein C resistance test. , 1998, Blood.
[89] D. Karussis,et al. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity? , 1998, Annals of neurology.
[90] C. Feighery,et al. Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders , 1998, British journal of haematology.
[91] J. Piette,et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. , 1998, The Journal of clinical investigation.
[92] G. Hughes,et al. The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid Syndrome , 1998, Thrombosis and Haemostasis.
[93] M. Vilardell‐Tarrés,et al. IgA Anticardiolipin Antibodies – Relation with other Antiphospholipid Antibodies and Clinical Significance , 1998, Thrombosis and Haemostasis.
[94] K. Drouvalakis,et al. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease. , 1998, The Journal of rheumatology.
[95] A. Escalante,et al. Neurological manifestations of antiphospholipid antibody syndrome , 1998, Lupus.
[96] Blann,et al. Autoantibodies directed against phospholipids or human β2‐glycoprotein 1 in HIV‐seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies , 1998, European journal of clinical investigation.
[97] F. Guillemin,et al. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis , 1998, Lupus.
[98] D. Kilpatrick. Factors affecting cardiolipin antibody assays: modification with polyethylene glycol compound , 1998, British journal of haematology.
[99] H. Takeya. Anti-β2-glycoprotein I (β2GPI) Monoclonal Antibodies with Lupus Anticoagulant-like Activity Enhance the β2GPI Binding to Phospholipids , 1997 .
[100] L. Berglund,et al. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[101] E. Anggard,et al. Oxidative Stress in Primary Antiphospholipid Syndr ome , 1997, Thrombosis and Haemostasis.
[102] J. Tervaert,et al. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. , 1997, Seminars in arthritis and rheumatism.
[103] J. Witztum,et al. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[104] A. Szczeklik,et al. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. , 1997, The Journal of rheumatology.
[105] A. Korczyn,et al. Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. , 1997, The Journal of clinical investigation.
[106] C. Porta,et al. Nitrite and Nitrate Plasma Levels, as Markers of Nitric Oxide Synthesis, in Antiphospholipid Antibodies-related Conditions and in Thrombotic Thrombocytopenic Purpura , 1997, Thrombosis and Haemostasis.
[107] J. Rand,et al. Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism. , 1997, The New England journal of medicine.
[108] P. Pagliaro,et al. CD36 Autoantibodies and Thrombotic Diathesis, Thrombocytopenia and Repeated Early Fetal Losses , 1997, Vox sanguinis.
[109] F. Guillemin,et al. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis , 1997, Lupus.
[110] I. Scharrer,et al. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups. , 1997, Blood.
[111] J. Matsuda,et al. Anti‐endothelial cell antibodies to the endothelial hybridoma cell line (EAhy926) in systemic lupus erythematosus patients with antiphospholipid antibodies , 1997, British journal of haematology.
[112] T. Barbui,et al. Different Anticoagulant and Immunological Properties of Anti-Prothrombin Antibodies in Patients with Antiphospholipid Antibodies , 1997, Thrombosis and Haemostasis.
[113] M. Rodríguez-García,et al. Annexin V autoantibodies in rheumatoid arthritis. , 1996, Annals of the rheumatic diseases.
[114] P. D. de Groot,et al. Lupus Anticoagulant is the Strongest Risk Factor for both Venous and Arterial Thrombosis in Patients with Systemic Lupus Erythematosus , 1996, Thrombosis and Haemostasis.
[115] M. Trojano,et al. Serum IgG to brain microvascular endothelial cells in multiple sclerosis , 1996, Journal of the Neurological Sciences.
[116] J. Rauch,et al. Antibodies against Phospholipids other than Cardiolipin: Potential Roles for Both Phospholipid and Protein , 1996, Lupus.
[117] L. Sammaritano,et al. Antiphospholipid Antibodies Activate Vascular Endothelial Cells , 1996, Lupus.
[118] J. Piette,et al. Do some antiphospholipid antibodies target endothelial cells? , 1996, Annales de medecine interne.
[119] A. Nurden,et al. Procoagulant activity and active calpain in platelet-derived microparticles. , 1996, Thrombosis research.
[120] L. Carreras,et al. Increased Plasma Thrombomodulin in Different Subgroups of Patients with Antiphospholipid and Anti β2 Glycoprotein I Antibodies , 1996, Thrombosis and Haemostasis.
[121] A. W. Boersma,et al. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin. , 1996, Cytometry.
[122] G. Escolar,et al. Antibodies to endothelial cells and to beta 2-glycoprotein I in the antiphospholipid syndrome: prevalence and isotype distribution. , 1996, British journal of rheumatology.
[123] À. Rovira,et al. Antibodies against endothelial cells in patients with multiple sclerosis , 1996, Acta neurologica Scandinavica.
[124] R. Huber,et al. Structural and functional characterisation of the voltage sensor in the ion channel human annexin V. , 1996, Journal of molecular biology.
[125] A. Biasiolo,et al. Autoantibodies to Phospholipid-binding Plasma Proteins in Patients with Thrombosis and Phospholipid-reactive Antibodies , 1996, Thrombosis and Haemostasis.
[126] T. Barbui,et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. , 1996, The American journal of medicine.
[127] O. Vaarala,et al. Antibodies to Prothrombin Imply a Risk of Myocardial Infarction in Middle-Aged Men , 1996, Thrombosis and Haemostasis.
[128] W. Cho,et al. Interactions of annexin V with phospholipid monolayers. , 1996, Biochimica et biophysica acta.
[129] J. Prieto,et al. Anticardiolipin antibodies in chronic hepatitis C: Implication of hepatitis C virus as the cause of the antiphospholipid syndrom , 1996, Hepatology.
[130] D. Discher,et al. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. , 1996, Blood.
[131] J. Lasala,et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. , 1995, The Journal of clinical investigation.
[132] Y. Wada,et al. Antibody to annexin V has anti‐phospholipid and lupus anticoagulant properties , 1995, American journal of hematology.
[133] J. Coste,et al. High levels of antibodies to annexins V and VI in patients with rheumatoid arthritis. , 1995, The Journal of rheumatology.
[134] V. Brancaccio,et al. Antiphospholipid Antibodies, Haemostatic Variables and Thrombosis – A Survey of 144 Patients , 1995, Thrombosis and Haemostasis.
[135] N. Nakamura,et al. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V. , 1994, Biochemical and biophysical research communications.
[136] N. Tandon,et al. Anti‐CD36 antibodies in patients with lupus anticoagulant and thrombotic complications , 1994, British journal of haematology.
[137] K. Kuettner,et al. Structural and functional comparison of anchorin CII (cartilage annexin V) and muscle annexin V. , 1994, Archives of biochemistry and biophysics.
[138] D. Alarcón-Segovia,et al. Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of beta 2-glycoprotein-I. , 1994, Journal of immunological methods.
[139] A. Tincani,et al. Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. , 1994, The Journal of rheumatology.
[140] S. Rapaport,et al. Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity. , 1994, Blood.
[141] S. Pierangeli,et al. Anticardiolipin wet workshop report. Fifth International Symposium on antiphospholipid antibodies. , 1994, American journal of clinical pathology.
[142] H. Pollard,et al. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. , 1994, Biochimica et biophysica acta.
[143] A. Doria,et al. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? , 1994, Annals of the rheumatic diseases.
[144] M. Khamashta,et al. Antibodies Against Platelet-Activating Factor in Patients with Antiphospholipid Antibodies , 1994, Lupus.
[145] M. Pegram,et al. Syndromes of Hypercoagulability and Thrombosis: A Review , 1994, Seminars in thrombosis and hemostasis.
[146] J. Matsuda,et al. Distinguishing β2‐glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibody with Tween 20 , 1993, British journal of haematology.
[147] J. Maclouf,et al. Antiphospholipid Antibodies Enhance Thrombin-Induced Platelet Activation and Thromboxane Formation , 1993, Thrombosis and Haemostasis.
[148] P. D. de Groot,et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? , 1993, Blood.
[149] A. Nurden,et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups , 1993 .
[150] P. Comfurius,et al. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. , 1992, Biochimica et biophysica acta.
[151] J. Bell,et al. Western blotting analysis in patients with MS using human brain vessels as antigen , 1992, Acta neurologica Scandinavica.
[152] J. Sixma,et al. Antiphospholipid Antibody Positive Sera Enhance Endothelial Cell Procoagulant Activity – Studies in a Thrombosis Model , 1992, Thrombosis and Haemostasis.
[153] R. Brey,et al. Antiphospholipid antibodies and complement activation in patients with cerebral ischemia. , 1992, Clinical and experimental rheumatology.
[154] J. Buyon,et al. Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. , 1992, The Journal of clinical investigation.
[155] T. Kawakatsu,et al. Anti-phospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura , 1992, Annals of Hematology.
[156] D. Niewoehner,et al. Some antiphospholipid antibodies inhibit phospholipase A2 activity. , 1992, The Journal of laboratory and clinical medicine.
[157] M. Galli,et al. Cofactors Involved in the Antiphospholipid Syndrome , 1992, Lupus.
[158] A. DeMichele,et al. Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies , 1991, British journal of haematology.
[159] P. D. de Groot,et al. Antibodies to platelets in patients with anti-phospholipid antibodies. , 1991, Blood.
[160] N. Yanagisawa,et al. Autoantibodies to each protein fraction extracted from cerebral endothelial cell membrane in the sera of patients with multiple sclerosis , 1989, Journal of Neuroimmunology.
[161] M. Entman,et al. Molecular Basis of Complement Activation in Ischemic Myocardium: Identification of Specific Molecules of Mitochondrial Origin That Bind Human Clq and Fix Complement , 1989, Circulation research.
[162] A. Shibata,et al. Coagulation studies in thrombotic thrombocytopenic purpura, with special reference to von willebrand factor and protein S , 1989, American journal of hematology.
[163] G. Hughes,et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. , 1988, Annals of the rheumatic diseases.
[164] C. Ming,et al. Enhancement of anti-phospholipid antibody activity by Tween 20. , 1988, Journal of immunological methods.
[165] M. Lockshin,et al. IgG but not IgM anti-phospholipid antibody binding is temperature dependent , 1988, Journal of Clinical Immunology.
[166] P. D. de Groot,et al. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. , 1988, Annals of the rheumatic diseases.
[167] J. Nimpf,et al. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. , 1987, Atherosclerosis.
[168] G. Hughes,et al. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. , 1987, Annals of the rheumatic diseases.
[169] P. Bomans,et al. Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-I , 1986 .
[170] I. Schousboe. beta 2-Glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. , 1985, Blood.
[171] Y. Asada,et al. Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. , 1985, Thrombosis research.
[172] S. Rapaport,et al. Thrombosis in patients with the lupus anticoagulant. , 1980, Annals of internal medicine.
[173] R. O'rourke,et al. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. , 1975, The Journal of clinical investigation.
[174] R. O'rourke,et al. Antibody-independent activation of human C1 after interaction with heart subcellular membranes. , 1973, Journal of immunology.
[175] E. Bowie,et al. THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. , 1963, The Journal of laboratory and clinical medicine.
[176] D. Jackson,et al. CIRCULATING ANTICOAGULANTS: A STUDY OF 40 CASES AND A REVIEW OF THE LITERATURE , 1961, Medicine.
[177] T. Fog,et al. [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.
[178] S. Lindsay,et al. Studies on the Coagulation Defect in a Case of Thrombocytopenic Purpura Complicated by Thrombosis. , 1946, The American journal of pathology.
[179] P. Hogg,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Lupus Anticoagulants Form Immune Complexes With Prothrombin and Phospholipid That Can Augment Thrombin Production in Flow , 2016 .
[180] L. Horstman,et al. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. , 2007, Thrombosis Research.
[181] M. Yamakuchi,et al. The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-b2-glycoprotein-1 , 2006 .
[182] Haupt,et al. Characterization of binding of human 12-glycoprotein I to cardiolipin , 2005 .
[183] L. Horstman,et al. Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. , 2004, Thrombosis research.
[184] F. Dignat-George,et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome , 2004, Thrombosis and Haemostasis.
[185] Y. Shoenfeld. Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unraveled. , 2003, Trends in immunology.
[186] Y. Shoenfeld,et al. Systemic Involvement in the Antiphospholipid Syndrome , 2002 .
[187] A. Rosato,et al. Some Patients with Antiphospholipid Syndrome Express hitherto Undescribed Antibodies to Cardiolipin-binding Proteins , 2001, Thrombosis and Haemostasis.
[188] J. Healey,et al. Antigenicity of putative phospholipid membrane-binding residues in factor VIII. , 2001, Blood.
[189] P. Youinou,et al. Oxidation of β2-glycoprotein I (β2GPI) by the Hydroxyl Radical Alters Phospholipid Binding and Modulates Recognition by anti- β2GPI Autoantibodies , 2001, Thrombosis and Haemostasis.
[190] M. Ishii,et al. Purification and Characterization of Factor VII Inhibitor Found in a Patient with Life Threatening Bleeding , 2000, Thrombosis and Haemostasis.
[191] G. FitzGerald,et al. HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY Ongoing Prothrombotic State in Patients With Antiphospholipid Antibodies : A Role for Increased Lipid Peroxidation , 1999 .
[192] J. del Pino-Montes,et al. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. , 1998, The Journal of rheumatology.
[193] D. W. Jones,et al. Factor XII Determinations in the Presence and Absence of Phospholipid Antibodies , 1998, Thrombosis and Haemostasis.
[194] Y. Ikeda,et al. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. , 1997, American journal of hematology.
[195] G. Hughes,et al. Up-Regulated Tissue Factor Expression in Antiphospholipid Syndrome , 1997, Thrombosis and Haemostasis.
[196] M. Umeda,et al. Specific Cross-reaction of IgG Anti-phospholipid Antibody with Platelet Glycoprotein IIIa , 1996, Thrombosis and Haemostasis.
[197] J. Nishioka,et al. β2-Glycoprotein I Modulates the Anticoagulant Activity of Activated Protein C on the Phospholipid Surface , 1996, Thrombosis and Haemostasis.
[198] J. Mcintyre,et al. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. , 1995, Blood.
[199] I. Sandlie,et al. The structural requirements for complement activation by IgG: does it hinge on the hinge? , 1995, Immunology today.
[200] H. Fillit,et al. Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes. , 1994, Blood.
[201] F. Violi,et al. Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus. , 1994, Blood.
[202] 松浦 栄次. Anticardiolipin antibodies recognize β[2]-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface , 1994 .
[203] R. Bick,et al. Antiphospholipid antibodies in coronary artery disease: a review. , 1994, Seminars in thrombosis and hemostasis.
[204] P. Reyes,et al. Heat inactivation of bovine serum used for blockade in immunoenzymatic assay is associated with spurious fall on the titers of anticardiolipin antibodies in primary antiphospholipid syndrome sera , 1993, Journal of clinical laboratory analysis.
[205] G. Rodgers,et al. Induction of endothelial cell tissue factor activity by sera from patients with antiphospholipid syndrome: a possible mechanism of thrombosis. , 1993, American journal of obstetrics and gynecology.
[206] Marcus John Beasley,et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells. , 1992, Clinical and experimental rheumatology.
[207] G. Hughes,et al. Anti-endothelial cell antibodies in retinal vasculitis. , 1992, Current eye research.
[208] C. Conley,et al. Circulating anticoagulant as a cause of hemorrhagic diathesis in man. , 1948, Bulletin of the Johns Hopkins Hospital.